These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents? Schönbeck U; Libby P Circulation; 2004 Jun; 109(21 Suppl 1):II18-26. PubMed ID: 15173059 [TBL] [Abstract][Full Text] [Related]
3. Cholesterol homeostasis and the pathophysiology of Alzheimer's disease. Blain JF; Poirier J Expert Rev Neurother; 2004 Sep; 4(5):823-9. PubMed ID: 15853509 [TBL] [Abstract][Full Text] [Related]
4. Statins--a cure-all for the brain? Menge T; Hartung HP; Stüve O Nat Rev Neurosci; 2005 Apr; 6(4):325-31. PubMed ID: 15803163 [TBL] [Abstract][Full Text] [Related]
5. Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease. Reiss AB; Siller KA; Rahman MM; Chan ES; Ghiso J; de Leon MJ Neurobiol Aging; 2004 Sep; 25(8):977-89. PubMed ID: 15212822 [TBL] [Abstract][Full Text] [Related]
6. Isoprenoids and Alzheimer's disease: a complex relationship. Cole SL; Vassar R Neurobiol Dis; 2006 May; 22(2):209-22. PubMed ID: 16406223 [TBL] [Abstract][Full Text] [Related]
7. Comparison of biochemical effects of statins and fish oil in brain: the battle of the titans. Farooqui AA; Ong WY; Horrocks LA; Chen P; Farooqui T Brain Res Rev; 2007 Dec; 56(2):443-71. PubMed ID: 17959252 [TBL] [Abstract][Full Text] [Related]
8. Statins as potential therapeutic agents in neuroinflammatory disorders. Stüve O; Youssef S; Steinman L; Zamvil SS Curr Opin Neurol; 2003 Jun; 16(3):393-401. PubMed ID: 12858078 [TBL] [Abstract][Full Text] [Related]
9. Toward immunomodulatory and anti-inflammatory properties of statins. Arnaud C; Braunersreuther V; Mach F Trends Cardiovasc Med; 2005 Aug; 15(6):202-6. PubMed ID: 16182129 [TBL] [Abstract][Full Text] [Related]
10. Statins in stroke: prevention, protection and recovery. Switzer JA; Hess DC Expert Rev Neurother; 2006 Feb; 6(2):195-202. PubMed ID: 16466299 [TBL] [Abstract][Full Text] [Related]
11. Do statins slow down Alzheimer's disease? A review. Caballero J; Nahata M J Clin Pharm Ther; 2004 Jun; 29(3):209-13. PubMed ID: 15153082 [TBL] [Abstract][Full Text] [Related]
12. HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration? Guymer RH; Chiu AW; Lim L; Baird PN Surv Ophthalmol; 2005; 50(2):194-206. PubMed ID: 15749309 [TBL] [Abstract][Full Text] [Related]
13. Does statin use decrease the amount of Alzheimer disease pathology in the brain? Silbert LC Neurology; 2007 Aug; 69(9):E8-11. PubMed ID: 17724280 [No Abstract] [Full Text] [Related]
15. HMG-CoA reductase inhibitors (statins) as anticancer drugs (review). Fritz G Int J Oncol; 2005 Nov; 27(5):1401-9. PubMed ID: 16211237 [TBL] [Abstract][Full Text] [Related]
16. Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats. Tanaka N; Katayama Y; Katsumata T; Otori T; Nishiyama Y Brain Res; 2007 Sep; 1169():125-32. PubMed ID: 17706949 [TBL] [Abstract][Full Text] [Related]
17. Potential roles for statins in critically ill patients. Weant KA; Cook AM Pharmacotherapy; 2007 Sep; 27(9):1279-96. PubMed ID: 17723082 [TBL] [Abstract][Full Text] [Related]
18. Statins: the next anti-endotoxin. Kruger PS Crit Care Resusc; 2006 Sep; 8(3):223-6. PubMed ID: 16930109 [TBL] [Abstract][Full Text] [Related]
19. Statin-mediated protective effects in the central nervous system: general mechanisms and putative role of stress proteins. Schmeer C; Kretz A; Isenmann S Restor Neurol Neurosci; 2006; 24(2):79-95. PubMed ID: 16720944 [TBL] [Abstract][Full Text] [Related]